Fate and propagation of endogenously formed Tau aggregates in neuronal cells
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Tau accumulation in the form of neurofibrillary tangles in the brain is a hallmark of tauopathies such as Alzheimer's disease (AD). Tau aggregates accumulate in brain regions in a defined spatiotemporal pattern and may induce the aggregation of native Tau in a prion-like manner. However, the underlying mechanisms of cell-to-cell spreading of Tau pathology are unknown and could involve encapsulation within exosomes, trans-synaptic passage, and tunneling nanotubes (TNTs). We have established a neuronal cell model to monitor both internalization of externally added fibrils, synthetic (K18) or Tau from AD brain extracts, and real-time conversion of microtubule-binding domain of Tau fused to a fluorescent marker into aggregates. We found that these endogenously formed deposits colabel with ubiquitin and p62 but are not recruited to macroautophagosomes, eventually escaping clearance. Furthermore, endogenous K18-seeded Tau aggregates spread to neighboring cells where they seed new deposits. Transfer of Tau aggregates depends on direct cell contact, and they are found inside TNTs connecting neuronal cells. We further demonstrate that contact-dependent transfer occurs in primary neurons and between neurons and astrocytes in organotypic cultures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194 · cited 3×
“…neuronal phospho-Tau first appears in the locus coeruleus and in the trans-entorhinal cortex before it spreads to the hippocampal formation and neocortex, following a predictable pattern (Braak & Braak, 1991; Braak et al, 2011; Jucker & Walker, 2011; Grinberg & Heinsen, 2017; Kaufman et al, 2018).”
BackgroundAggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148 · cited 3×
“We observed that newly formed Tau aggregates were not associated with mitochondria, early endosomes, nor Golgi structures as shown by the lack of colocalization with specific markers for these organelles (TOM20, EEA1, or Furin plus Giantin, respectively; Fig EV3A).”
BackgroundNanotubular Highways for Intercellular Organelle Transport
Rustom, A., Saffrich, R., Markovic, I., Walther, P., & Gerdes, H.-H. (2004) · Science · doi:10.1126/science.1093133 · Cited by 2,038
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663 · cited 1×
“Like prions, Tau fibrils act as templates for conversion of native protein to a fibrillar form, initiating a self-amplifying cascade, and can spread from their initial production site to other areas in the brain, following well-defined pathways (Jucker & Walker, 2013).”
BackgroundInfluentialExtensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Alzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252 · cited 4×
“In order to monitor endogenous Tau aggregate generation and propagation in a time-dependent manner, we established a human neuronal model of neuroblastoma SH-SY5Y cells expressing the Tau aggregating domain RD (Frost et al, 2009a; Holmes et al, 2014; Sanders et al, 2014).”
BackgroundInfluentialSelf-citationTau protein liquid–liquid phase separation can initiate tau aggregation
Wegmann, S., Eftekharzadeh, B., Tepper, K., Zoltowska, K. M., Bennett, R. E., Dujardin, S., Laskowski, P. R., MacKenzie, D., Kamath, T., Commins, C., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798049 · Cited by 1,102
Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies
Sanders, D. W., Kaufman, S. K., DeVos, S. L., Sharma, A. M., Mirbaha, H., Li, A., Barker, S. J., Foley, A. C., Thorpe, J. R., Serpell, L. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.047 · Cited by 986
Self-citationHeparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Holmes, B. B., DeVos, S. L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., Ouidja, M. O., Brodsky, F. M., Marasa, J., Bagchi, D. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301440110 · Cited by 859
Self-citationAmbadipudi, S., Biernat, J., Riedel, D., Mandelkow, E., & Zweckstetter, M. (2017) · Nature Communications · doi:10.1038/s41467-017-00480-0 · Cited by 782 · cited 1×
“Recent findings suggest that Tau proteins form liquid droplets, or RNA-Tau droplets that undergo liquid–liquid phase separation (LLPS), which in turn could initiate Tau aggregation (Ambadipudi et al, 2017; Wegmann et al, 2018).”
BackgroundProteopathic tau seeding predicts tauopathy in vivo
Holmes, B. B., Furman, J. L., Mahan, T. E., Yamasaki, T. R., Mirbaha, H., Eades, W. C., Belaygorod, L., Cairns, N. J., Holtzman, D. M., & Diamond, M. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411649111 · Cited by 696 · cited 2×
“In order to monitor endogenous Tau aggregate generation and propagation in a time-dependent manner, we established a human neuronal model of neuroblastoma SH-SY5Y cells expressing the Tau aggregating domain RD (Frost et al, 2009a; Holmes et al, 2014; Sanders et al, 2014).”
BackgroundMethodSelf-citationPathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders
Jucker, M., & Walker, L. C. (2011) · Annals of Neurology · doi:10.1002/ana.22615 · Cited by 622 · cited 2×
“…neuronal phospho-Tau first appears in the locus coeruleus and in the trans-entorhinal cortex before it spreads to the hippocampal formation and neocortex, following a predictable pattern (Braak & Braak, 1991; Braak et al, 2011; Jucker & Walker, 2011; Grinberg & Heinsen, 2017; Kaufman et al, 2018).”
BackgroundWu, J. W., Herman, M., Liu, L., Simoes, S., Acker, C. M., Figueroa, H., Steinberg, J. I., Margittai, M., Kayed, R., Zurzolo, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394528 · Cited by 537
Self-citationGuo, J. L., Narasimhan, S., Changolkar, L., He, Z., Stieber, A., Zhang, B., Gathagan, R. J., Iba, M., McBride, J. D., Trojanowski, J. Q., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160833 · Cited by 440
Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes
Abounit, S., Bousset, L., Loria, F., Zhu, S., de Chaumont, F., Pieri, L., Olivo‐Marin, J., Melki, R., & Zurzolo, C. (2016) · The EMBO Journal · doi:10.15252/embj.201593411 · Cited by 414
Self-citationWiring through tunneling nanotubes--from electrical signals to organelle transfer
Abounit, S., & Zurzolo, C. (2012) · Journal of Cell Science · doi:10.1242/jcs.083279 · Cited by 386 · cited 1×
“They represent a novel mechanism for long-range intercellular communication operating in different cell types and in many diseases (Abounit & Zurzolo, 2012; 1 Unité de Trafic Membranaire et Pathogenèse, Institut Pasteur, Paris, France 2 Center for Alzheimer’s and Neurodegenerative Diseases, Peter…”
BackgroundSelf-citationYamada, K., Cirrito, J. R., Stewart, F. R., Jiang, H., Finn, M. B., Holmes, B. B., Binder, L. I., Mandelkow, E.-M., Diamond, M. I., Lee, V. M.-Y., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2569-11.2011 · Cited by 351
Self-citationAlzheimer's disease affects limbic nuclei of the thalamus
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00305867 · Cited by 328 · cited 3×
“The degree of tauopathy in the brain correlates with the cognitive decline in AD (Braak & Braak, 1991), suggesting that spreading of Tau deposits could be associated with disease progression.”
BackgroundTunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies
Tardivel, M., Bégard, S., Bousset, L., Dujardin, S., Coens, A., Melki, R., Buée, L., & Colin, M. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0386-4 · Cited by 305
Loss of Bin1 Promotes the Propagation of Tau Pathology
Calafate, S., Flavin, W., Verstreken, P., & Moechars, D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.063 · Cited by 265
Kaufman, S. K., Del Tredici, K., Thomas, T. L., Braak, H., & Diamond, M. I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1855-6 · Cited by 259
Self-citationConformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change
Frost, B., Ollesch, J., Wille, H., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805627200 · Cited by 224 · cited 4×
“In order to monitor endogenous Tau aggregate generation and propagation in a time-dependent manner, we established a human neuronal model of neuroblastoma SH-SY5Y cells expressing the Tau aggregating domain RD (Frost et al, 2009a; Holmes et al, 2014; Sanders et al, 2014).”
BackgroundInfluentialSelf-citationGoedert, M., & Spillantini, M. G. (2017) · Molecular Brain · doi:10.1186/s13041-017-0298-7 · Cited by 213 · cited 1×
“Dysfunction of Tau is also involved in multiple disorders linked to neurodegeneration and dementia, collectively termed tauopathies (Goedert & Spillantini, 2017).”
BackgroundTau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs)
Rauch, J. N., Chen, J. J., Sorum, A. W., Miller, G. M., Sharf, T., See, S. K., Hsieh-Wilson, L. C., Kampmann, M., & Kosik, K. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-24904-z · Cited by 211 · cited 1×
“Published data suggest that exogenous Tau fibrils can enter the cells by endocytosis or by micropinocytosis, being directed to late endosomes or lysosomes (Frost et al, 2009b; Wu et al, 2013; Holmes et al, 2013; Calafate et al, 2015, 2016; Papadopoulos et al, 2017; Rauch et al, 2018).”
BackgroundAbounit, S., Wu, J. W., Duff, K., Victoria, G. S., & Zurzolo, C. (2016) · Prion · doi:10.1080/19336896.2016.1223003 · Cited by 206
Self-citationCytosolic Fc receptor TRIM21 inhibits seeded tau aggregation
McEwan, W. A., Falcon, B., Vaysburd, M., Clift, D., Oblak, A. L., Ghetti, B., Goedert, M., & James, L. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607215114 · Cited by 201
Chen, J. J., Nathaniel, D. L., Raghavan, P., Nelson, M., Tian, R., Tse, E., Hong, J. Y., See, S. K., Mok, S.-A., Hein, M. Y., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009432 · Cited by 170 · cited 2×
“Compared to other assays (Guo et al, 2016a; Guo et al, 2016b; McEwan et al, 2017; Chen et al, 2019, 2020), we were able to record in real time the cellular conversion of endogenously expressed RD upon exogenous addition of K18 fibrils, using a live-cell analysis system consisting of an automated…”
BackgroundMethodRoberts, M., Sevastou, I., Imaizumi, Y., Mistry, K., Talma, S., Dey, M., Gartlon, J., Ochiai, H., Zhou, Z., Akasofu, S., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0884-2 · Cited by 135
Nobuhara, C. K., DeVos, S. L., Commins, C., Wegmann, S., Moore, B. D., Roe, A. D., Costantino, I., Frosch, M. P., Pitstick, R., Carlson, G. A., et al. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.01.022 · Cited by 120 · cited 1×
“Previously described anti-Tau antibodies have been shown to impair uptake, seeding, or transfer (Funk et al, 2015; Nobuhara et al, 2017; Albert et al, 2019; Hoskin et al, 2019; Weisová et al, 2019; Roberts et al, 2020).”
BackgroundDistinct Therapeutic Mechanisms of Tau Antibodies
Funk, K. E., Mirbaha, H., Jiang, H., Holtzman, D. M., & Diamond, M. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657924 · Cited by 111 · cited 1×
“Previously described anti-Tau antibodies have been shown to impair uptake, seeding, or transfer (Funk et al, 2015; Nobuhara et al, 2017; Albert et al, 2019; Hoskin et al, 2019; Weisová et al, 2019; Roberts et al, 2020).”
BackgroundSelf-citation
Cited by
Chakraborty, R., Nonaka, T., Hasegawa, M., & Zurzolo, C. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05835-8 · Cited by 190
“Amyloido-genic proteins such as prions [23], amyloid β [24], tau [25], mHTT [26], and α -Syn [27] have been reported to use TNTs as a route for spreading from one cell to another in in vitro co-cultures and in brain slices.”
Self-citationDilsizoglu Senol, A., Samarani, M., Syan, S., Guardia, C. M., Nonaka, T., Liv, N., Latour-Lambert, P., Hasegawa, M., Klumperman, J., Bonifacino, J. S., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001287 · Cited by 134
“In addition to α-syn fibrils, other amyloidogenic proteins such as prion protein [50–52], huntingtin [53], and tau [52,54,55] use TNTs as highways for transfer to naive cells, suggesting that TNTs are common routes for the spread of pathogenic proteins between cells.”
BackgroundSelf-citationZhou, C., Huang, M., Wang, S., Chu, S., Zhang, Z., & Chen, N. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110921 · Cited by 34
“TNTs have been identified in various cell lines, including neuronal cells, astrocytes (Chastagner et al., 2020), microglia (Chakra-borty et al., 2023), immune cells (Halasz et al., 2018), and tumor cells (Pinto et al., 2021).”
Tunneling nanotubes: A novel pharmacological target for neurodegenerative diseases?
Wang, X.-T., Sun, H., Chen, N.-H., & Yuan, Y.-H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105541 · Cited by 22
Metadata
- Authors
- Chastagner, P., Loria, F., Vargas, J. Y., Tois, J., I Diamond, M., Okafo, G., Brou, C., & Zurzolo, C.
- Venue
- EMBO Molecular Medicine
- Published
- 2020-11-12
- Volume
- 12
- Issue
- 12
- Pages
- e12025-e12025
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W3103278178
- Cited by
- 80
- References
- 33
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.